Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
MedPro Rx, Inc. Named One of 50 Fastest-Growing Women-Owned Companies in North America
Specialty Pharmacy Owned by City of Raleigh, N.C. Mayor Nancy McFarlane, Recognized by American Express OPEN And Women Presidents’ Organization (WPO) - May 04, 2012 - MedPro Rx, Inc.
Unbound Medicine and Datapharm Launch Mobile Medicines Compendium UK - Comprehensive Database of Pharmaceutical Product Information Now Available for Mobile Download
Unbound Medicine, a leader in knowledge management solutions for health care, and Datapharm, an independent organization dedicated to improving public health and safety by providing up-to-date, accurate and comprehensive information about medicines, announce the release of Medicines Compendium UK for mobile devices. Medicines Compendium UK represents the first mobile application with the unabridged Summary of Product Characteristics (SPCs) for more than 5,000 unique pharmaceutical products. - May 03, 2012 - Unbound Medicine
"Global Nuclear Medicine Market Will Reach $4.5bn by 2022" Visiongain Report Predicts
A new report by visiongain, a London-based business information provider, predicts that the global market for nuclear medicine will be worth $4.5bn by 2022. The market generated sales of $1.4bn in 2010. - May 03, 2012 - visiongain
Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
pharmaCline's Diabecline antibiotic ointment has been recognized as the Bronze Award winner for Best New Pharmaceutical Product by the Edison Awards. - May 01, 2012 - pharmaCline
Ameridose Supports Pharmacy Leadership Forum
Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is honored to sponsor the Executive Forum segment of Boston University School of Management’s 2012 Pharmacy Leadership Institute program. This year’s Executive Forum is titled... - May 01, 2012 - Ameridose, LLC
AdvantaPure(R) to Spotlight Molded Components & Single Use Items at Spring 2012 Trade Shows; Schedule Includes Pharmaceutical & Bioprocess Events
High purity tubing manufacturer AdvantaPure will exhibit its single use products and molded components for the pharmaceutical and bioprocess industries at two upcoming events, Interphex and the Single Use Applications Conference. AdvantaPure will highlight single use tubing of silicone and TPE and molded fitting connections. When combined into a manifold assembly, the products help reduce leaks associated with barbed-style fittings that can lead to wasted batches of costly pharmaceuticals. - April 28, 2012 - NewAge Industries, Inc.
Pharmaceutical Operations Provider, Inc. Announces Brent Galletta Has Joined Their Management Team as Vice President of Business Development
Pharmaceutical Operations Provider has brought Brent Galletta in as Vice President of Business Development to implement new sales and support strategies. These strategies include developing strong longstanding relationships with clients looking to provide their sales representatives with the most comprehensive PDMA compliant mobile sales CRM. - April 27, 2012 - Pharmaceutical Operations Provider
Foamix Obtains US Patent "Waterless Hydrophilic Foam" for Dermatological and Gynecological Drugs, Such as Antibiotics, Antifungals and Corticosteroids
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - April 27, 2012 - Foamix Ltd
Carotech to Share Latest Breakthrough in Tocomin SupraBio Research at SupplySide MarketPlace, New York
They will be sharing with customers and visitors the latest clinical data of their patented and bioenhanced natural full spectrum palm tocotrienol complex. - April 27, 2012 - Carotech Inc.
Ameridose Sponsors Health Connect Partners 2012 Spring Hospital Pharmacy Conference
Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is pleased to be a sponsor of the Health Connect Partners Spring Hospital Pharmacy Conference for a second consecutive year. The conference will take place from May 7-9, 2012 at the Hyatt Regency in... - April 26, 2012 - Ameridose, LLC
Ameridose Unveils Innovative First Quarter Sustainability Enhancements
Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is pleased to share exciting sustainability news for the first quarter of 2012. Aiming for the ultimate in energy efficiency, Ameridose is currently in the process of installing a made-in-the-USA... - April 24, 2012 - Ameridose, LLC
Increasing Cardiac Patient Base Drives the Indian Cardiovascular Pharma Market, Finds Netscribes
Netscribes (India) Pvt. Ltd., launches a report on the Cardiovascular Pharmaceuticals Market in India 2012 as part of Netscribes’ Healthcare Industry report series. - April 21, 2012 - Netscribes, Inc.
Gabbard Wellness Announces Strategic Partnership with Stark Service Solutions, LLC
New partnership makes available quality health and wellness products to the hospitality industry. - April 19, 2012 - Gabbard Wellness Group Inc.
"Smoking Cessation Drugs Market Will Reach $2.4 Billion in 2012" Visiongain Report Predicts
A new report by visiongain predicts that the world market for smoking cessation medicines will reach $2.4 billion for 2012. - April 16, 2012 - visiongain
Syndicated Columnist & Talk Show Host Sandy Zimmerman Announced an Interview with Dr. Mary Block, D.O., Regarding the Safety of Our Drugs Today
Sandy Zimmerman feels, “The public think our medicines are safe because they were approved by the FDA but what is the process of drug approval?” - April 11, 2012 - Sandy Zimmerman
GS1 EPCglobal Software Certification Mark for EPCIS Awarded to FastPoint Technologies
FastPoint Technologies is recognized as a provider of certified software solutions for Electronic Product Code Information Services (EPCIS). - April 11, 2012 - FastPoint Technologies
High Infectious Disease Incidence Drives the Indian Anti-Infective Pharma Market, Finds Netscribes
Netscribes (India) Pvt. Ltd., launches a report on the Anti-Infective Pharmaceuticals Market in India 2012 as part of Netscribes’ Healthcare Industry report series. - April 08, 2012 - Netscribes, Inc.
Dr. Birgit Schoeberl to Discuss Using Mathematical Models to Set Design Criteria for Antibody-Based Therapies in Rosa’s "Impact" World-Wide Webinar Series
Dr. Schoeberl will present “Using Mathematical Models To Set Design Criteria For Antibody-Based Therapies” April 17, 2012. - April 04, 2012 - Rosa & Co LLC
Indian Anti-Diabetic Pharma Market is Largely Driven by Huge Diabetic Patient Base, Finds Netscribes
Netscribes (India) Pvt. Ltd., launches a report on the Anti-Diabetic Pharmaceuticals Market in India 2012 as part of Netscribes’ Healthcare Industry report series. - April 01, 2012 - Netscribes, Inc.
Rosa to Present Two Lectures at the European Foundation of Medicinal Chemists Conference
Rosa to Present The MQM Standard and Lead Optimization Using Systems Pharmacology Modeling - April 01, 2012 - Rosa & Co LLC
"Eleven Indian Companies in the Top 50 Generics Manufacturers Worldwide" States Visiongain Report
A new report by visiongain lists 11 Indian companies among the top 50 generic drug manufacturers worldwide. Five Indian companies (Ranbaxy, Cipla, Dr. Reddy’s, Sun Pharma and Lupin) are in the top 20, the joint-highest representation for any country. While Teva remains the largest player in the industry, with revenues of over $10bn for its generics portfolio in 2011, the competition is growing ever more intense. - March 29, 2012 - visiongain
Rosa to Present Systems Pharmacology Workshop at 3rd Annual World PK/PD Summit
Rosa Workshop Presents the MQM Quality Standard for Mechanistic Modeling - March 26, 2012 - Rosa & Co LLC
New Revolutionary Mental Illness Treatment Offers Hope for Multiple Disorders and is Non Evasive
Transcranial Magnetic Stimulation Therapy (TMS) is explained by Psychiatrist Dr. Tarique Perera on Smart Health Talk Radio show, April 22 at 4:00 pm PST on KCAARadio.com. TMS can work when other treatments fail, and offers a new treatment option. - March 23, 2012 - Smart Health Talk
Medimix International and Sanofi Pasteur to Present Results of Social Media Monitoring Study PMRG ANC - Orlando, March 27th, 2012
Medimix International and Sanofi Pasteur will present at the PMRG ANC results of an innovative social media study which used a powerful new tracking platform to monitor social media conversations around the globe. Scouring sites representative of English, Spanish, French, Portuguese, German and Chinese (or 80% of the languages used by online populations), the flagged mentions were analyzed by both machine and human to correctly categorize content, overall sentiment, and identify influencers. - March 23, 2012 - Medimix International
Rising Number of Cancer Cases Making India Potential Market for Anti-Cancer Drugs, Finds Netscribes
Netscribes (India) Pvt. Ltd., launches a report on the Oncology Pharmaceuticals Market in India 2011 as part of Netscribes’ Healthcare Industry report series. - March 21, 2012 - Netscribes, Inc.
Detroit R&D and ALPCO Diagnostics Sign Distribution Agreement
ALPCO Diagnostics and Detroit R&D agree to a distribution partnership in North America. - March 20, 2012 - ALPCO
Foamix’s Minocycline Foam – 100% Effective in Impetigo Phase II Clinical Trial with No Side Effects. 80% Improved Significantly After 3 Days of Treatment.
Targets a $1 billion a year market. Foamix, a clinical stage specialty pharmaceutical company, announced today the successful completion of the Phase II clinical trial of Minocycline foam in Impetigo patients. Minocycline Foam has shown to be highly effective against bacteria, including some multi-drug resistant strains (such as MRSA). - March 20, 2012 - Foamix Ltd
Paragon Innovations Helps Diabetics Cut the (Refrigerator) Cord, with Design of New Temperature Control Device
Say goodbye to coolers and ice packs. Available this summer from Kewl Innovations, amazing nano-technology-driven device will keep medicine temps consistent – for days. - March 19, 2012 - Paragon Innovations, Inc.
"Ophthalmic Drugs Market Will Reach $18.7 Billion in 2012" Visiongain Report Predicts
A new report by visiongain predicts that the world market for ophthalmic drugs will reach $18.7 billion for 2012. That revenue forecast appears in Ophthalmic Drugs: World Market Prospects 2012-2022, published in March 2012. Visiongain is a business information provider based in London, UK. - March 18, 2012 - visiongain
High Infectious Diseases Incidence Drives the Indian Anti-Infective Pharmaceutical Market, Finds Netscribes
Netscribes (India) Pvt. Ltd., launches a report on the Anti-Infective Pharmaceuticals Market in India 2011, as part of Netscribes’ Healthcare Industry report series. - March 17, 2012 - Netscribes, Inc.
Indian Anti-Diabetic Pharma Market is Largely Driven by Huge Diabetic Patient Base, Finds Netscribes
Netscribes (India) Pvt. Ltd., launches a report on the Anti-Diabetic Pharmaceuticals Market in India 2011 as part of Netscribes’ Healthcare Industry report series. - March 17, 2012 - Netscribes, Inc.
New Book Release
CGMP University inc of San Jose announced the release of two books: 1. How to design a Pharmaceutical Quality system. 2. Principles of design controls for medical device. - March 16, 2012 - cGMP UNIVERSITY INC.
Dr. Joga Gobburu to Discuss the Impact of Pharmacometrics on Drug Approvals in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”
Dr. Gobburu will present “Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions” March 20, 2012. - March 16, 2012 - Rosa & Co LLC
Foamix Granted Comprehensive US Patent for PerFoam® – Ideal Foam Treatment for Head Lice and Scabies
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - March 15, 2012 - Foamix Ltd
The 2012 BioProcess International Awards - Honoring a Decade of BioProcess
Awarding 4 Awards in pillar of bioprocess: Upstream, downstream and manufacturing. Awards include Technology of the Decade, Technical Application of the Decade, Collaboration of the Decade, and Thought Leader of the Decade - March 14, 2012 - BioProcess International
Rising Tendencies Towards Self-Treatment Drives the Indian OTC Drug Market, Finds Netscribes
Netscribes (India) Pvt. Ltd., launches a report on the OTC Pharmaceuticals Market in India 2011 as part of Netscribes’ Healthcare Industry report series. - March 14, 2012 - Netscribes, Inc.
Foamix Obtains US Patent for Iodine Foam – Innovative Treatment for Heat Burns and Warfare Materials, as Well as Fungal and Bacterial Infection
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - March 13, 2012 - Foamix Ltd
New Foamix US Patent: "Foamable Compositions, Kits and Methods for Hyperhidrosis" - First in Class Foam for Excessive Sweating
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - March 13, 2012 - Foamix Ltd
Data Migrations Spike; Sentrx Assists Customers in Addressing New Guidance Concerning the Development Safety Update Report (DSUR)
Sentrx, an industry leader in providing outsourced drug safety solutions, comprehensive pharmacovigilance solutions and data management services, weighs in on new DSUR guidance. - March 10, 2012 - Sentrx
Rosa PK/PD Collaboration with Pfizer to be Presented at ASCPT 2012
PK/PD analyses used to support the rationale for therapeutic strategies targeting myostatin pathway. - March 10, 2012 - Rosa & Co LLC
The Growing Pharmaceutical Sector Drives the Indian Pharmacy Retail Market, Finds Netscribes
Netscribes (India) Pvt. Ltd., launches its Pharmacy Retail Market in India Report 2012 covering one of the very potential markets in India having strong growth prospects in future. It is a part of Netscribes’ Healthcare Series reports. - March 09, 2012 - Netscribes, Inc.
Cypin Production’s Branded Generics Conference Attracts Unexpected Breadth of Attendees
Some truly ground-breaking topics and dynamic speakers brought attendees from all over the world to the first Branded Generics TM conference held recently in Philadelphia. - March 09, 2012 - CYPIN PRODUCTION LLC
The New AdvantaTube(TM) Sealer & Sterile Welder Available Now from AdvantaPure(R); Manufactured to Seal & Weld AdvantaFlex(R) Biopharmaceutical Grade Tubing
Specially developed for the biopharmaceutical industry, the AdvantaTube Sterile Welder and the AdvantaTube Sealer are now offered by AdvantaPure. The units are programmed to weld and seal the company’s AdvantaFlex biopharmaceutical grade TPE tubing and were added to the product line due to customer requests. The ability to seal and weld tubing in a biopharmaceutical process is an important function, and not all tubing materials possess the capability to be welded and sealed. - March 07, 2012 - NewAge Industries, Inc.
IonSense Introduces the DART®-OS Source. Expands Its OpenSpot Mass Spectrometry™ Product Line
OpenSpot® Sample Cards Facilitate Simpler Analysis, Eliminating Most Consumables and Solvents, Reducing Lab Waste. Exhibited at Pittcon 2012. Booth #2609. - March 06, 2012 - IonSense, Inc.
Ameridose Continues Outstanding Sustainability Performance
Ameridose, LLC, nationwide provider of sterile admixing services to hospital pharmacies, is pleased to present outstanding 2011 sustainability results. Recycled materials generated from Ameridose facilities totaled 1.9 million lbs. Corrugated cardboard dominated with over 600,000 lbs, empty glass... - March 06, 2012 - Ameridose, LLC
Sentrx Introduces Patient Safety Nation – The No. 1 Pool of Patient Safety Focused Professionals on the Planet
Sentrx, an industry leader in providing outsourced drug safety solutions and comprehensive pharmacovigilance solutions, introduces the Patient Safety Nation. - March 04, 2012 - Sentrx
DAVA Oncology, LP- Alexander E. Denes, M.D., F.A.C.P. Joins DAVA Oncology as Medical Director
DAVA Oncology, LP is pleased to announce the addition of Alex Denes, MD as a member of the medical oncology support staff. Dr. Denes is from Washington University School of Medicine, where he currently serves as Associate Professor of Medicine. Dr. Denes has an extensive background as a clinician... - March 03, 2012 - Dava Oncology, LP
"Cancer Drug Market Will Reach $75 Billion in 2012" Visiongain Report Predicts
A new report by visiongain predicts that the world market for cancer-treating drugs will reach $75 billion for 2012. That revenue forecast appears in Leading Anti-Cancer Drugs and Associated Market 2012-2022, published in February 2012. Visiongain is a business information provider based in London, UK. - March 02, 2012 - visiongain
Rosa Announces Publication of Its PhysioPD™ Model Qualification Method and Series of Educational Events
Series of Seminars and Workshops to be held in 2012 across the US and in Europe. - March 01, 2012 - Rosa & Co LLC
CPC Scientific Announces Its Peptide Facility Passes 2nd Successful FDA Inspection
CPC Scientific is pleased to announce that its 50,000 sf cGMP peptide facility has successfully passed a second US Food and Drug Administration (FDA) inspection. It involved the investigator inspecting CPC Scientific’s peptide production facilities, manufacturing processes, laboratory control... - February 27, 2012 - CPC Scientific